# Post-approval Study of Transcarotid Artery Revascularization in Standard Risk Patients With Significant Carotid Artery Disease

> **NCT05365490** · — · COMPLETED · sponsor: **Silk Road Medical** · enrollment: 344 (actual)

## Conditions studied

- Carotid Artery Diseases

## Interventions

- **PROCEDURE:** Transcarotid Artery Revascularization (TCAR)

## Key facts

- **NCT ID:** NCT05365490
- **Lead sponsor:** Silk Road Medical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2025-07-22
- **Final completion:** 2025-07-22
- **Target enrollment:** 344 (ACTUAL)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05365490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05365490, "Post-approval Study of Transcarotid Artery Revascularization in Standard Risk Patients With Significant Carotid Artery Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05365490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*